- Home
- SLQT vs EYPT Comparison
SLQT vs EYPT Comparison
Compare SLQT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | EYPT |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.6M | 1.5B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SLQT | EYPT |
|---|---|---|
| Price | $1.37 | $18.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.88 | ★ $29.60 |
| AVG Volume (30 Days) | 921.8K | ★ 1.3M |
| Earning Date | 02-09-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,563,142,000.00 | $42,339,000.00 |
| Revenue This Year | $13.00 | N/A |
| Revenue Next Year | $7.65 | N/A |
| P/E Ratio | $11.06 | ★ N/A |
| Revenue Growth | ★ 13.16 | N/A |
| 52 Week Low | $1.33 | $3.91 |
| 52 Week High | $6.86 | $19.11 |
Technical Indicators
Market Signals| Indicator | SLQT | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 66.55 |
| Support Level | $1.33 | $16.52 |
| Resistance Level | $1.46 | $19.00 |
| Average True Range (ATR) | 0.08 | 1.04 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 13.04 | 74.24 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.